Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 26;193(29):E1129-E1136.
doi: 10.1503/cmaj.202391.

The use and impact of monoclonal antibody biologics during pregnancy

Anne Pham-Huy  1 , Karina A Top  2 , Cora Constantinescu  2 , Cynthia H Seow  2 , Darine El-Chaâr  2
Affiliations
Review

The use and impact of monoclonal antibody biologics during pregnancy

Anne Pham-Huy et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Anne Pham-Huy reports presentation honoraria from the Canadian Society of Allergy and Clinical Immunology and the University of Calgary. She is the chair of Immunize Canada. Karina Top is a co-investigator on grants from GSK, outside the submitted work. She also reports an honorarium from the Canadian Society of Allergy and Clinical Immunology, payment for expert testimony from the Ontario Ministry of the Attorney General and conference support from the Canadian Public Health Association, outside the submitted work. She is the director of the AMMI Canada Council and a member of the Canadian Association for Immunization Research Evaluation and Education. Cora Constantinescu reports speaker fees from GSK and Pfizer. Cynthia Seow sits on the advisory boards for and reports speaker fees from Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience. No other competing interests were declared.

References

    1. Kaplan GG, Bernstein CN, Coward S, et al. . The impact of inflammatory bowel disease in Canada 2018: epidemiology. J Can Assoc Gastroenterol 2019;2(Suppl 1): S6–16. - PMC - PubMed
    1. Mahadevan U, Wolf DC, Dubinsky M, et al. . Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:286–92, quiz e24. - PMC - PubMed
    1. Pham-Huy A, Sadarangani M, Huang V, et al. . From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert Rev Clin Immunol 2019; 15:221–9. - PubMed
    1. Nguyen GC, Seow CH, Maxwell C, et al. . The Toronto Consensus Statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 2016;150:734–57.e1. - PubMed
    1. Flint J, Panchal S, Hurrell A, et al. . BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford). 2016;55:1698–702. - PubMed

MeSH terms